Bio-Techne (TECH) Exec Sells $283K in Shares for Tax Purposes
BIO-TECHNE Corp
Subscribe to track TECH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Bio-Techne (TECH) Exec Sells $283K in Shares for Tax Purposes
Company: BIO-TECHNE Corp (TECH) Form: 4 | Filed: 2025-11-05 Significance: Low
Insider: Geist William Title: PRESIDENT, PROTEIN SCIENCES | Relationship: Officer
Transaction: • Type: Tax Withholding (Sell-to-cover) • Shares: 4,520 • Price: $62.57 • Value: $282,816 • Owned After: 20,503
Key Insight: This was an automatic sale to cover tax liabilities from the vesting of 9,911 Restricted Stock Units (RSUs) and is not considered a discretionary trade reflecting insider sentiment.
Market Context: The transaction value represents a negligible 0.0029% of the company's $9.74 billion market capitalization.
Comprehensive Analysis
SEC Filing Analysis: BIO-TECHNE Corp (TECH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A company executive automatically sold shares to cover tax obligations arising from vested Restricted Stock Units (RSUs). This is a routine, non-discretionary transaction.
- Market Impact: Neutral. The transaction is immaterial in size and does not signal a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | BIO-TECHNE Corp |
| Ticker Symbol | TECH |
| CIK | 0000842023 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Geist William |
| CIK | 0001832210 |
| Title/Position | PRESIDENT, PROTEIN SCIENCES |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-03 |
| Transaction Code | F - Payment of tax liability by withholding securities |
| Security Type | Common Stock |
| Shares Involved | 4,520 |
| Price Per Share | $62.57 |
| Total Value | $282,816.40 |
| Shares Owned After | 20,503 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $282,816.40 |
| % of Market Cap | 0.0029% |
| Shares Transacted | 4,520 |
| % of Shares Outstanding | 0.0029% |
| Post-Transaction Ownership | 20,503 shares (0.0132% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The transaction's value of approximately $283k is negligible compared to Bio-Techne's market capitalization of $9.74 billion.
- Ownership Concentration: The insider's post-transaction ownership of 20,503 shares constitutes a very small fraction (0.0132%) of the total shares outstanding, indicating low ownership concentration from this individual.
- Transaction Significance: The sale represents an insignificant percentage of both market cap and shares outstanding, falling far below the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is a non-discretionary "sell-to-cover" event, which is automated and required to satisfy tax obligations on equity compensation. It does not reflect a voluntary decision by the insider to reduce their stake in the company.
Volume & Sentiment
- Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
- Sentiment Indicator: Neutral. The market typically disregards 'F' coded transactions as they are not indicative of an insider's outlook.
Additional Context
Transaction Notes
- This disposition (Code 'F') was executed to cover taxes related to the simultaneous vesting of 9,911 Restricted Stock Units, which were acquired by the insider (Code 'M'). The net result was an increase in the insider's total shareholdings.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
